01 April 2004
Severe preeclampsia and eclampsia in Kerman, Iran: complications and outcomes
Bibi Shahnaz Aali, Jila Ghafoorian, Sakineh Mohamad-AlizadehMed Sci Monit 2004; 10(4): CR163-167 :: ID: 11630
Abstract
Background:Our objective was to assess the frequency, epidemiological factors, complications, and outcome of severe preeclampsia and eclampsia and compare them according to severity of the condition in Kerman, southeastern Iran.Material/Methods: A prospective study was performed on 200 consecutive cases of severe preeclampsia and eclampsia referred to the Kerman University Maternity Center from June 2001 to December 2002. Demographic data and complications were described and severe preeclampsia and eclampsia compared using t-student’s and chi2 tests.Results: Severe preeclampsia occurred in 3% and eclampsia in 0.6% of deliveries during the period of study. The majority of patients were young and primigravida, especially in the eclampsia group. 72.7% of eclamptic patients suffered their first convulsion at home and not in the presence of medical help. HELLP syndrome, disseminated intravascular coagulation, acute renal failure, neurological complications, and acute respiratory distress syndrome were the main maternal complications, all occurring more frequently in eclamptic patients. The frequency of pulmonary edema, placental abruption, postpartum hemorrhage, and aspiration pneumonia was not significantly different between the two groups. More than half of patients underwent cesarean delivery. Early neonatal mortality rate was 13% in the entire cohort. All six maternal deaths during the period of the study occurred in eclamptic cases (mortality rate 18%), four relating to patients who had not received prenatal care.Conclusions: Severe preeclampsia carries a high risk of maternal and neonatal morbidities and mortality in Kerman. This risk increases in the presence of eclampsia, particularly in neglected cases who have not sought prenatal care.
Keywords: Cesarean Section, Eclampsia - complications, HELLP Syndrome - etiology, Infant Mortality, Infant, Newborn, Iran, Pre-Eclampsia - complications, Pregnancy, Cesarean Section, Eclampsia - complications, HELLP Syndrome - etiology, Infant Mortality, Infant, Newborn, Iran, Pre-Eclampsia - complications, Pregnancy
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Comparative Analysis of Laser Therapies for Striae Distensae: Fractional CO₂ vs Combined Q-Switch Nd:YAGMed Sci Monit In Press; DOI: 10.12659/MSM.947464
Database Analysis
Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter AccessMed Sci Monit In Press; DOI: 10.12659/MSM.947298
Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947462
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Most Viewed Current Articles
17 Jan 2024 : Review article 7,110,480
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,343
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,671
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,887
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912